3DHISTECH
Private Company
Total funding raised: $7.6M
Overview
3DHISTECH is a pioneering, privately-held digital pathology company with over 30 years of experience, headquartered in Budapest, Hungary. It has established itself as a full-spectrum vendor offering hardware, software, and services for the complete digitization of pathology workflows, serving both clinical diagnostics and life science research markets. The company has a significant installed base of over 3,800 units and is expanding its portfolio with innovative technologies like 3D micro-CT imaging. Recent regulatory certifications (IVDR, MDSAP) underscore its focus on quality and global market expansion, particularly in diagnostics.
Technology Platform
Integrated digital pathology platform comprising the Pannoramic family of whole slide scanners (brightfield, fluorescence, confocal, polarization), the Pannoramic-X micro-CT scanner for 3D tissue imaging, and a suite of software for image analysis, management, and 3D visualization (DVREAL).
Funding History
2Opportunities
Risk Factors
Competitive Landscape
3DHISTECH competes in the digital pathology market against major players like Roche (Ventana), Philips, Leica Biosystems (Danaher), and Hamamatsu. Its competitive differentiation lies in its claimed scanner speed, a comprehensive range of imaging modalities within single devices, its integrated vendor-locked ecosystem, and its novel micro-CT technology for 3D imaging, which is less common among mainstream pathology vendors.